Vaccine doses allocated to African countries hardest hit by mpox surge
On Nov. 6, 2024, the World Health Organization announced that the Access and Allocation Mechanism (AAM) for mpox…
living microbes discovered in 2-billion-year-old rock in South Africa
On Oct. 2, 2024, a team of researchers from the University of Tokyo announced they had discovered living…
Novavax received full Marketing Authorization for potype COVID-19 vaccine Nuvaxovid in UK
On Oct. 18, 2023, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
Clinical trial of HIV vaccine began in United States and South Africa
On Sept. 20, 2023, the National Institutes of Health announced that a trial of a preventive HIV vaccine…
Novavax and Serum Institute of India announced full product registration in South Africa of Novavax COVID-19 vaccine
On Sept. 13, 2022, Novavax and Serum Institute of India, the world’s largest vaccine manufacturer by volume, announced…
BioNTech started construction of first mRNA vaccine manufacturing facility in Africa
On Jun. 23, 2022, BioNTech announced it had reached a milestone in the establishment of scalable mRNA vaccine…
Novavax filed in the UK for expanded conditional Marketing Authorization of COVID-19 vaccination booster in adult
On Jun. 2, 2022, Novavax announced the submission of a request to the Medicines and Healthcare products Regulatory…
IAVI and Moderna launched first-in-Africa clinical trial of mRNA HIV vaccine development program
On May 18, 2022, Moderna and the nonprofit scientific research organization IAVI announced that the first participant screenings…
WHO announced first technology recipients of mRNA vaccine hub
On Feb. 18, 2022, the WHO announced the first six countries that will receive the technology needed to…
Novavax and Serum Institute filed for Emergency Use Authorization of Novavax’ COVID-19 vaccine in South Africa
On Jan. 10, 2022, Novavax and Serum Institute of India announced a regulatory submission to the South African…
Johnson & Johnson COVID-19 vaccine demonstrated 85 percent effectiveness against hospitalization in South Africa when Omicron was dominant
On Dec. 30, 2021, Johnson & Johnson announced preliminary results from the South African Phase 3b Sisonke study…
Cocrystal Pharma’s COVID-19 oral and intranasal/pulmonary protease inhibitors exhibited powerful in vitro potency against the SARS-CoV-2 Omicron variant
On Dec. 22, 2021, Cocrystal Pharma announced that in vitro studies demonstrate its oral and intranasal/pulmonary SARS-CoV-2 main…
Twist Bioscience began shipping synthetic RNA positive controls for Omicron (B.1.1.529/BA.1) SARS-CoV-2 variant for Development of Accurate Diagnostic Tests
On Dec. 15, 2021, Twist Bioscience announced that synthetic RNA positive controls were available for the SARS-CoV-2 Omicron…
First confirmed case of Omicron variant detected in the United States
On Dec. 1, 2021, the California and San Francisco Departments of Public Health confirmed that a recent case…
Hologicï¾’s COVID-19 tests detected Omicron variant
On Nov. 29, 2021, Hologic announced that its three SARS-CoV-2 tests all detected the recently emerged Omicron variant…
WHO announced classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern
On Nov. 26, 2021, the World Health Organization announced that the Technical Advisory Group on SARS-CoV-2 Virus Evolution…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
Study confirmed virus variants reduce protection against COVID-19
On Aug. 26, 2021, Oregon Health & Science University (OHSU) announced a laboratory study from found that blood…
MPP, WHO, AFRIGEN, BIOVAC, SAMRC and Africa CDC announced LOI for tech transfer hub in South Africa
On Jul. 30, 2021, the Medicines Patent Pool and the World Health Organization, Afrigen Biologics, the Biologicals and…
Cocrystal’s SARS-CoV-2 3CL protease lead CDI-45205 demonstrated broad-spectrum activity against SARS-CoV-2 Delta and Gamma variants
On Jul. 29, 2021, Cocrystal Pharma announced that its SARS-CoV-2 3CL protease lead CDI-45205 and several analogs showed…
Pfizer and BioNTech announced collaboration with Biovac to manufacture and distribute COVID-19 vaccine doses in Africa
On Jul. 21, 2021, Pfizer and BioNTech announced the signing of a letter of intent with The Biovac…
Moderna provides a clinical update on neutralizing activity of COVID-19 vaccine on emerging variants
On Jun. 29, 2021, Moderna announced new results from in vitro neutralization studies of sera from individuals vaccinated…
First trial participants vaccinated with Oxford COVID-19 variant vaccine
On Jun. 28, 2021, the University of Oxford in partnership with AstraZeneca began vaccinations for a new phase…
WHO supported South African consortium to establish first COVID mRNA vaccine technology transfer hub
On Oct. 6, 2021, the World Health Organization and its COVAX partners are working with a South African…
Novavax announces positive data from three complementary studies of COVID-19 Beta variant strain vaccine
On Jun. 11, 2021, Novavax announced preclinical and clinical data on the company’s original recombinant protein COVID-19 vaccine…
Altimmune demonstrated strong neutralization of South African variant in preclinical study of intranasal AdCOVIDï¾™
On May 26, 2021, Altimmune announced new results from a preclinical study demonstrating the ability of its AdCOVID…
ImmunityBio expanded South African trials of T-cell-based COVID-19 vaccine candidate as ﾑUniversal Boostﾒ in vaccinated subjects
On May 25, 2021, ImmunityBio announced two South African studies to examine the potential for using its hAd5…
AstraZeneca COVID-19 vaccine Vaxzevria authorised for emergency use in Japan
On May 21, 2021, AstraZeneca announced that it had been granted a special approval for emergency use in…
Second-generation COVID-19 vaccine candidate, CV2CoV, demonstrated high immunogenicity in preclinical study
On May 13, 2021, CureVac announced together with its collaboration partner GSK, first preclinical data in a rat…
INOVIO’s Pan-COVID-19 vaccine candidate (INO-4802) induces broad immunity against vviral variants in preclinical studies
On May 12, 2021, Inovio Pharma announced that its next-generation Pan-COVID-19 vaccine candidate, INO-4802, induced potent neutralizing antibodies…
NEJM published phase 2b clinical trial results demonstrating efficacy of COVID-19 vaccine against B.1.351 variant
On May 5, 2021, Novavax announced the publication of results from the initial primary analysis of a Phase…